María Inés Figueroa

Mpox in people with advanced HIV infection: a global case series

Andrea Alemany, Michael Marks, Jezer I Lezama Mora et al. · The Lancet · 2023 · 452 citations · Full text

Advanced Hiv Infection, Sexual Health, Treatment And Prevention +8

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Pedro Cahn, Jaime Andrade‐Villanueva, José Ramón Arribas et al. · The Lancet Infectious Diseases · 2014 · 154 citations

Open Label, Human Retrovirus, Antiviral Drug Development +9

Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART

Alberto Zalar, María Inés Figueroa, B Ruibal-Ares et al. · Antiviral Research · 2010 · 101 citations · Full text

Long Term Haart, Medicine, Human Retrovirus +9

Dolutegravir–lamivudine as initial therapy in HIV‐1 infected, ARV‐naive patients, 48‐week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study

Pedro Cahn, María José Rolón, María Inés Figueroa et al. · Journal of the International AIDS Society · 2017 · 101 citations · Full text

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters

M. Eugenia Socías, Omar Sued, Natalia Laufer et al. · Journal of the International AIDS Society · 2011 · 56 citations · Full text